Abiopharma

Arrowhead Pharmaceuticals to Participate in Upcoming September 2025 Conferences

Rezolute to Participate in Upcoming Investor Conferences

BridgeBio to Participate in September Investor Conferences

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

Dyne Therapeutics to Present at Upcoming Investor Conferences

Context Therapeutics to Participate in Upcoming Investor Conferences

ADC - ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025

ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025

New Form 8-K - Amylyx Pharmaceuticals, Inc. Filed: 2025-08-27 AccNo: 0001193125-25-189109 Size: 131 KB Item 8.01: Other Events

Zimmer Biomet Holdings, Inc. Notification

New Form 8-K - BioXcel Therapeutics, Inc. Filed: 2025-08-27 AccNo: 0001104659-25-083402 Size: 245 KB Item 8.01: Other Events

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

Verastem Oncology to Present at Upcoming Investor Conferences

HERTHENA-Breast04 Phase 3 Trial of Patritumab Deruxtecan Initiated in Patients with Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer Previously Treated with Endocrine Therapy

Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)